Williams MT

School of Psychology, University of Ottawa, 136 Jean-Jacques Lussier, Vanier Hall, Ottawa, ON, K1N 6N5, Canada. Monnica.Williams@uOttawa.ca.

9 papers · ORCID

ArticleMDMA

Changes in trauma symptoms of discrimination after MDMA-assisted psychotherapy for posttraumatic stress disorder.

Williams MT, Faber SC, Sloshower J +2

Europe PMC2026
ArticlePsilocybin

Expert recommendations for Germany's integration of psychedelic-assisted therapy.

Perez Rosal SR, La Torre JT, Birnkammer S +3

Europe PMC2024
ArticlePsilocybin

Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.

Davis AK, Arterberry BJ, Xin Y +3

Europe PMC2022
ArticlePsilocybin

Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.

Rosa WE, Sager Z, Miller M +19

Europe PMC2022
ArticlePsychedelics

The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness.

Campbell M, Williams MT

Europe PMC2021
ArticlePsilocybin

Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.

Fogg C, Michaels TI, de la Salle S +2

Europe PMC2021
ArticlePsychedelics

Increases in Psychological Flexibility Mediate Relationship Between Acute Psychedelic Effects and Decreases in Racial Trauma Symptoms Among People of Color.

Davis AK, Xin Y, Sepeda ND +2

Europe PMC2021
ArticlePsilocybin

People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.

Williams MT, Davis AK, Xin Y +4

Europe PMC2021
ArticlePsychedelics

Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature.

Michaels TI, Purdon J, Collins A +1

Europe PMC2018